cagrilintide dosage with tirzepatide twice a week Once-weekly for weight management in people overweight and obesity: multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial cagrilintide dosage with Cagrilintide Dosage with Tirzepatide: Dual

After 2026 beneficiaries need to enroll in Part D plan that opts into BALANCE to maintain access Due to the short-term nature of the Bridge Program, Part D beneficiaries who desire to maintain access to GLP-1s for weight loss management in 2027 will need to enroll in a Part D plan that opts into the BALANCE Model

Gum and mint sales were strong, thanks to the rise in GLP-1s

Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial

The next milestone is a Rule 702 expert hearing in September 2026

Song Y, Wu C, Zhang X, Bian W, Liu N, Yin S

Such medical news demonstrates that delayed gastric emptying leads to gastroparesis (stomach paralysis)